United States Healthcare Providers & Services

CVS Health Corporation (CVS)

CVS Health Corporation witnessed a notable insider purchase recently, as EVP Prem S. Shah acquired shares valued at approximately $2 million on November 6, 2026. This activity follows a period where the stock price declined by 11.7% over the last quarter, despite a positive earnings report showing a 29% beat on expectations.
Ticker: CVS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CVS Health Corporation. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Shah Prem S EVP and Group President Officer
Transaction date
Purchase
Price
173.18
Quantity 50,285 -46.0%
Value US$3,170,549
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
111.48
Quantity 1,066 -0.9%
Value US$4,449,627
1.3
FARAH ROGER N Director Non-Executive Director
Transaction date
Proposed sale
Price
364.47
Quantity 5,948
Value US$3,840,158
3.2
AGUIRRE FERNANDO Director Non-Executive Director
Transaction date
Proposed sale
Price
94.69
Quantity 29,737
Value US$2,815,797
3.2
AGUIRRE FERNANDO Director Non-Executive Director
Transaction date
Proposed sale
Price
94.69
Quantity 2,263
Value US$214,283
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
96.28
Quantity 800 -0.0%
Value US$77,026
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
95.67
Quantity 66,881 -1.3%
Value US$6,398,204
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
94.81
Quantity 152,691 -2.8%
Value US$14,476,038
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
93.48
Quantity 797,628 -12.8%
Value US$74,559,554
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
95.18
Quantity 151 -0.0%
Value US$14,372
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
94.45
Quantity 1,983,387 -24.2%
Value US$187,326,935
0.9
Mandadi Tilak EVP, Chief Exp & Tech Officer Officer
Transaction date
Sale
Price
89.58
Quantity 69,551 -87.3%
Value US$6,230,379
0.9
TILAK MANDADI Officer Officer
Transaction date
Proposed sale
Price
89.58
Quantity 69,551
Value US$6,230,719
0.8
Finucane Anne A. Non-Executive Director
Transaction date
Sale
Price
71.02
Quantity 7,500 -25.3%
Value US$532,650
0.8
Finucane Anne A. Director Non-Executive Director
Transaction date
Proposed sale
Price
70.97
Quantity 7,500
Value US$532,275
3.1
SANSONE GUY P Non-Executive Director
Transaction date
Purchase
Price
63.70
Quantity 1,570 +15.0%
Value US$100,009
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
66.67
Quantity 150,000 -1.8%
Value US$10,000,710
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
67.99
Quantity 96,999 -1.1%
Value US$6,595,272
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
67.37
Quantity 1,226,933 -12.7%
Value US$82,654,673
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
69.66
Quantity 373,776 -3.7%
Value US$26,035,592
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
68.38
Quantity 222,556 -2.2%
Value US$15,218,980
3.7
ROBBINS LARRY Non-Executive Director
Transaction date
Sale
Price
67.39
Quantity 1,679,736 -14.1%
Value US$113,190,186
3.6
Clark James David SVP, Cont & Chief Acct Officer Officer
Transaction date
Sale
Price
66.35
Quantity 7,513 -47.2%
Value US$498,488
3.6
Clark James David Officer Officer
Transaction date
Proposed sale
Price
66.35
Quantity 7,513
Value US$498,489
2.8
Mahoney Michael F Non-Executive Director
Transaction date
Purchase
Price
66.70
Quantity 30,000 +320.6%
Value US$2,001,000
3.1
Nelson Steven H EVP and President, Aetna Officer
Transaction date
Purchase
Price
53.70
Quantity 24 New position
Value US$1,289
3.6
CAPOZZI HEIDI B EVP and Chief People Officer Officer
Transaction date
Purchase
Price
56.85
Quantity 35 +70.0%
Value US$1,990
3.6
CAPOZZI HEIDI B EVP and Chief People Officer Officer
Transaction date
Purchase
Price
62.24
Quantity 10 +25.0%
Value US$622
3.6
CAPOZZI HEIDI B EVP and Chief People Officer Officer
Transaction date
Purchase
Price
56.47
Quantity 35 +700.0%
Value US$1,976
3.1
LUDWIG EDWARD J Non-Executive Director
Transaction date
Purchase
Price
53.88
Quantity 1,000 +4.8%
Value US$53,879
2.8
Mahoney Michael F Non-Executive Director
Transaction date
Purchase
Price
54.49
Quantity 9,181 +5246.3%
Value US$500,294
3.1
PREM S SHAH Officer Officer
Transaction date
Proposed sale
Price
76.95
Quantity 29,473
Value US$2,267,924
3.1
Shah Prem S EVP and Pres-Pharm, Consumer W Officer
Transaction date
Sale
Price
76.95
Quantity 29,473 -42.6%
Value US$2,267,947
3.1
LUDWIG EDWARD J Non-Executive Director
Transaction date
Purchase
Price
70.47
Quantity 2,000 +10.7%
Value US$140,930
3.6
Clark James David SVP, Cont & Chief Acct Officer Officer
Transaction date
Sale
Price
74.94
Quantity 23,128 -83.1%
Value US$1,733,212
3.6
Clark James David SVP, Cont & Chief Acct Officer Officer
Transaction date
Sale
Price
74.79
Quantity 2,631 -8.6%
Value US$196,792
3.6
Clark James David Officer Officer
Transaction date
Proposed sale
Price
74.92
Quantity 25,759
Value US$1,929,930
2.1
Lynch Karen S President and CEO Executive Director
Transaction date
Purchase
Price
69.75
Quantity 14,000 +3.4%
Value US$976,567
3.3
Moriarty Thomas M EVP & General Counsel Officer
Transaction date
Planned sale
Price
98.24
Quantity 36,490 -5.7%
Value US$3,584,869
3.3
Moriarty Thomas M EVP & General Counsel Officer
Transaction date
Planned sale
Price
98.40
Quantity 100,976 -14.2%
Value US$9,936,311
2.3
Lotvin Alan EVP&President-PharmacyServices Officer
Transaction date
Planned sale
Price
104.00
Quantity 22,541 -17.1%
Value US$2,344,264
2.3
Lotvin Alan EVP&President-PharmacyServices Officer
Transaction date
Planned sale
Price
98.00
Quantity 50,501 -31.6%
Value US$4,949,098
2.3
Lotvin Alan EVP&President-PharmacyServices Officer
Transaction date
Planned sale
Price
98.00
Quantity 70,398 -39.2%
Value US$6,899,004
Finke Daniel P EVP/Pres, Health Care Benefits Officer
Transaction date
Planned sale
Price
100.00
Quantity 9,546 -22.9%
Value US$954,600
3.1
Shah Prem S EVP and Co-President of Retail Officer
Transaction date
Planned sale
Price
105.00
Quantity 3,130 -6.7%
Value US$328,650
3.1
Shah Prem S EVP and Co-President of Retail Officer
Transaction date
Planned sale
Price
105.00
Quantity 4,103 -8.1%
Value US$430,815
3.1
Shah Prem S EVP and Co-President of Retail Officer
Transaction date
Planned sale
Price
105.00
Quantity 5,719 -10.9%
Value US$600,495
3.1
Shah Prem S EVP and Co-President of Retail Officer
Transaction date
Planned sale
Price
105.00
Quantity 3,157 -6.3%
Value US$331,485
3.1
Shah Prem S EVP and Co-President of Retail Officer
Transaction date
Planned sale
Price
105.00
Quantity 845 -1.8%
Value US$88,725
Finke Daniel P EVP/Pres, Health Care Benefits Officer
Transaction date
Planned sale
Price
100.00
Quantity 5,941 -15.6%
Value US$594,100
Finke Daniel P EVP/Pres, Health Care Benefits Officer
Transaction date
Planned sale
Price
100.13
Quantity 12,032 -24.0%
Value US$1,204,764
Finke Daniel P EVP/Pres, Health Care Benefits Officer
Transaction date
Planned sale
Price
100.13
Quantity 27,166 -35.1%
Value US$2,720,132
Finke Daniel P EVP/Pres, Health Care Benefits Officer
Transaction date
Planned sale
Price
100.13
Quantity 16,161 -24.4%
Value US$1,618,201
3.1
Shah Prem S EVP and Co-President of Retail Officer
Transaction date
Sale
Price
106.65
Quantity 2,935 -4.7%
Value US$313,018
3.1
Shah Prem S EVP and Co-President of Retail Officer
Transaction date
Sale
Price
106.65
Quantity 1,689 -2.8%
Value US$180,132
3.3
Moriarty Thomas M EVP & General Counsel Officer
Transaction date
Sale
Price
105.00
Quantity 51,361 -5.8%
Value US$5,392,905
3.1
LUDWIG EDWARD J Non-Executive Director
Transaction date
Purchase
Price
105.90
Quantity 1,000 +5.8%
Value US$105,904
1.6
Brennan Troyen A EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
110.00
Quantity 47,937 -25.7%
Value US$5,273,070
2.3
Lotvin Alan EVP&President-PharmacyServices Officer
Transaction date
Planned sale
Price
106.50
Quantity 21,386 -25.9%
Value US$2,277,566
3.6
Clark James David SVP, Cont & Chief Acct Officer Officer
Transaction date
Planned sale
Price
109.00
Quantity 6,059 -25.7%
Value US$660,431
Roberts Jonathan C EVP & Chief Operating Officer Officer
Transaction date
Planned sale
Price
107.50
Quantity 68,482 -39.0%
Value US$7,361,815
Roberts Jonathan C EVP & Chief Operating Officer Officer
Transaction date
Planned sale
Price
95.00
Quantity 108,870 -50.4%
Value US$10,342,650
1.6
Brennan Troyen A EVP and Chief Medical Officer Officer
Transaction date
Sale
Price
90.00
Quantity 28,159 -16.9%
Value US$2,534,310
1.6
Brennan Troyen A EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
88.00
Quantity 80,802 -36.9%
Value US$7,110,576
1.6
Brennan Troyen A EVP and Chief Medical Officer Officer
Transaction date
Sale
Price
88.00
Quantity 1,955 -0.9%
Value US$172,040
2.3
Lotvin Alan EVP&President-PharmacyServices Officer
Transaction date
Planned sale
Price
83.67
Quantity 2,781 -4.4%
Value US$232,686
1.6
Brennan Troyen A EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
86.00
Quantity 67,552 -32.1%
Value US$5,809,472
Finke Daniel P EVP/Pres, Health Care Benefits Officer
Transaction date
Planned sale
Price
86.60
Quantity 37,594 -61.7%
Value US$3,255,640
3.3
Moriarty Thomas M EVP & General Counsel Officer
Transaction date
Planned sale
Price
86.00
Quantity 109,469 -100.0%
Value US$9,414,334
1.6
Brennan Troyen A EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
84.00
Quantity 9,477 -6.1%
Value US$796,068
2.3
Boratto Eva C EVP & CFO Officer
Transaction date
Planned sale
Price
80.00
Quantity 4,905 -4.1%
Value US$392,400
3.3
Moriarty Thomas M EVP & General Counsel Officer
Transaction date
Planned sale
Price
77.00
Quantity 2,420 -100.0%
Value US$186,340
3.3
Moriarty Thomas M EVP & General Counsel Officer
Transaction date
Planned sale
Price
77.00
Quantity 101,003 -97.7%
Value US$7,777,231
3.6
Clark James David SVP, Cont & Chief Acct Officer Officer
Transaction date
Planned sale
Price
76.00
Quantity 5,350 -42.5%
Value US$406,600
3.3
Moriarty Thomas M EVP & General Counsel Officer
Transaction date
Planned sale
Price
76.15
Quantity 62,943 -100.0%
Value US$4,793,109
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-06 2026-11-06 B Purchase
3.1
Shah Prem S

EVP and Group President

Officer
50,285 -46.0%
173.18
US$3,170,549 		50,285 -46.0% 173.18 US$3,170,549
2026-05-21 2026-05-21 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
1,066 -0.9%
111.48
US$4,449,627 		1,066 -0.9% 111.48 US$4,449,627
2026-05-21 2026-05-21 PrS Proposed sale
1.3
FARAH ROGER N

Director

Non-Executive Director
5,948
364.47
US$3,840,158 		5,948 364.47 US$3,840,158
2026-05-22 2026-05-20 PrS Proposed sale
3.2
AGUIRRE FERNANDO

Director

Non-Executive Director
29,737
94.69
US$2,815,797 		29,737 94.69 US$2,815,797
2026-05-22 2026-05-20 PrS Proposed sale
3.2
AGUIRRE FERNANDO

Director

Non-Executive Director
2,263
94.69
US$214,283 		2,263 94.69 US$214,283
2026-05-21 2026-05-20 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
800 -0.0%
96.28
US$77,026 		800 -0.0% 96.28 US$77,026
2026-05-21 2026-05-20 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
66,881 -1.3%
95.67
US$6,398,204 		66,881 -1.3% 95.67 US$6,398,204
2026-05-21 2026-05-20 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
152,691 -2.8%
94.81
US$14,476,038 		152,691 -2.8% 94.81 US$14,476,038
2026-05-21 2026-05-20 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
797,628 -12.8%
93.48
US$74,559,554 		797,628 -12.8% 93.48 US$74,559,554
2026-05-21 2026-05-19 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
151 -0.0%
95.18
US$14,372 		151 -0.0% 95.18 US$14,372
2026-05-21 2026-05-19 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
1,983,387 -24.2%
94.45
US$187,326,935 		1,983,387 -24.2% 94.45 US$187,326,935
2026-05-11 2026-05-08 S Sale
0.9
Mandadi Tilak

EVP, Chief Exp & Tech Officer

Officer
69,551 -87.3%
89.58
US$6,230,379 		69,551 -87.3% 89.58 US$6,230,379
2026-05-08 2026-05-08 PrS Proposed sale
0.9
TILAK MANDADI

Officer

Officer
69,551
89.58
US$6,230,719 		69,551 89.58 US$6,230,719
2025-08-29 2025-08-20 S Sale
0.8
Finucane Anne A.
Non-Executive Director
7,500 -25.3%
71.02
US$532,650 		7,500 -25.3% 71.02 US$532,650
2025-08-19 2025-08-20 PrS Proposed sale
0.8
Finucane Anne A.

Director

Non-Executive Director
7,500
70.97
US$532,275 		7,500 70.97 US$532,275
2025-06-09 2025-06-05 B Purchase
3.1
SANSONE GUY P
Non-Executive Director
1,570 +15.0%
63.70
US$100,009 		1,570 +15.0% 63.70 US$100,009
2025-05-06 2025-05-06 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
150,000 -1.8%
66.67
US$10,000,710 		150,000 -1.8% 66.67 US$10,000,710
2025-05-06 2025-05-05 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
96,999 -1.1%
67.99
US$6,595,272 		96,999 -1.1% 67.99 US$6,595,272
2025-05-06 2025-05-05 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
1,226,933 -12.7%
67.37
US$82,654,673 		1,226,933 -12.7% 67.37 US$82,654,673
2025-05-06 2025-05-02 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
373,776 -3.7%
69.66
US$26,035,592 		373,776 -3.7% 69.66 US$26,035,592
2025-05-06 2025-05-02 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
222,556 -2.2%
68.38
US$15,218,980 		222,556 -2.2% 68.38 US$15,218,980
2025-05-06 2025-05-02 S Sale
3.7
ROBBINS LARRY
Non-Executive Director
1,679,736 -14.1%
67.39
US$113,190,186 		1,679,736 -14.1% 67.39 US$113,190,186
2025-03-07 2025-03-05 S Sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
7,513 -47.2%
66.35
US$498,488 		7,513 -47.2% 66.35 US$498,488
2025-03-05 2025-03-05 PrS Proposed sale
3.6
Clark James David

Officer

Officer
7,513
66.35
US$498,489 		7,513 66.35 US$498,489
2025-02-19 2025-02-18 B Purchase
2.8
Mahoney Michael F
Non-Executive Director
30,000 +320.6%
66.70
US$2,001,000 		30,000 +320.6% 66.70 US$2,001,000
2026-01-27 2025-01-23 B Purchase
3.1
Nelson Steven H

EVP and President, Aetna

Officer
24 New position
53.70
US$1,289 		24 New position 53.70 US$1,289
2025-10-14 2024-10-23 B Purchase
3.6
CAPOZZI HEIDI B

EVP and Chief People Officer

Officer
35 +70.0%
56.85
US$1,990 		35 +70.0% 56.85 US$1,990
2025-10-14 2024-10-02 B Purchase
3.6
CAPOZZI HEIDI B

EVP and Chief People Officer

Officer
10 +25.0%
62.24
US$622 		10 +25.0% 62.24 US$622
2025-10-14 2024-09-09 B Purchase
3.6
CAPOZZI HEIDI B

EVP and Chief People Officer

Officer
35 +700.0%
56.47
US$1,976 		35 +700.0% 56.47 US$1,976
2024-05-02 2024-05-02 B Purchase
3.1
LUDWIG EDWARD J
Non-Executive Director
1,000 +4.8%
53.88
US$53,879 		1,000 +4.8% 53.88 US$53,879
2024-05-02 2024-05-02 B Purchase
2.8
Mahoney Michael F
Non-Executive Director
9,181 +5246.3%
54.49
US$500,294 		9,181 +5246.3% 54.49 US$500,294
2024-02-16 2024-02-16 PrS Proposed sale
3.1
PREM S SHAH

Officer

Officer
29,473
76.95
US$2,267,924 		29,473 76.95 US$2,267,924
2024-02-16 2024-02-16 S Sale
3.1
Shah Prem S

EVP and Pres-Pharm, Consumer W

Officer
29,473 -42.6%
76.95
US$2,267,947 		29,473 -42.6% 76.95 US$2,267,947
2023-11-06 2023-11-03 B Purchase
3.1
LUDWIG EDWARD J
Non-Executive Director
2,000 +10.7%
70.47
US$140,930 		2,000 +10.7% 70.47 US$140,930
2023-08-04 2023-08-03 S Sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
23,128 -83.1%
74.94
US$1,733,212 		23,128 -83.1% 74.94 US$1,733,212
2023-08-04 2023-08-03 S Sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
2,631 -8.6%
74.79
US$196,792 		2,631 -8.6% 74.79 US$196,792
2023-08-03 2023-08-03 PrS Proposed sale
3.6
Clark James David

Officer

Officer
25,759
74.92
US$1,929,930 		25,759 74.92 US$1,929,930
2023-05-05 2023-05-03 B Purchase
2.1
Lynch Karen S

President and CEO

Executive Director
14,000 +3.4%
69.75
US$976,567 		14,000 +3.4% 69.75 US$976,567
2022-12-16 2022-12-15 PlS Planned sale
3.3
Moriarty Thomas M

EVP & General Counsel

Officer
36,490 -5.7%
98.24
US$3,584,869 		36,490 -5.7% 98.24 US$3,584,869
2022-12-16 2022-12-15 PlS Planned sale
3.3
Moriarty Thomas M

EVP & General Counsel

Officer
100,976 -14.2%
98.40
US$9,936,311 		100,976 -14.2% 98.40 US$9,936,311
2022-08-05 2022-08-04 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
22,541 -17.1%
104.00
US$2,344,264 		22,541 -17.1% 104.00 US$2,344,264
2022-08-05 2022-08-03 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
50,501 -31.6%
98.00
US$4,949,098 		50,501 -31.6% 98.00 US$4,949,098
2022-08-05 2022-08-03 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
70,398 -39.2%
98.00
US$6,899,004 		70,398 -39.2% 98.00 US$6,899,004
2022-08-05 2022-08-03 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
9,546 -22.9%
100.00
US$954,600 		9,546 -22.9% 100.00 US$954,600
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
3,130 -6.7%
105.00
US$328,650 		3,130 -6.7% 105.00 US$328,650
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
4,103 -8.1%
105.00
US$430,815 		4,103 -8.1% 105.00 US$430,815
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
5,719 -10.9%
105.00
US$600,495 		5,719 -10.9% 105.00 US$600,495
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
3,157 -6.3%
105.00
US$331,485 		3,157 -6.3% 105.00 US$331,485
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
845 -1.8%
105.00
US$88,725 		845 -1.8% 105.00 US$88,725
2022-04-06 2022-04-05 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
5,941 -15.6%
100.00
US$594,100 		5,941 -15.6% 100.00 US$594,100
2022-04-06 2022-04-04 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
12,032 -24.0%
100.13
US$1,204,764 		12,032 -24.0% 100.13 US$1,204,764
2022-04-06 2022-04-04 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
27,166 -35.1%
100.13
US$2,720,132 		27,166 -35.1% 100.13 US$2,720,132
2022-04-06 2022-04-04 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
16,161 -24.4%
100.13
US$1,618,201 		16,161 -24.4% 100.13 US$1,618,201
2022-03-18 2022-03-17 S Sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
2,935 -4.7%
106.65
US$313,018 		2,935 -4.7% 106.65 US$313,018
2022-03-18 2022-03-17 S Sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
1,689 -2.8%
106.65
US$180,132 		1,689 -2.8% 106.65 US$180,132
2022-03-17 2022-03-15 S Sale
3.3
Moriarty Thomas M

EVP & General Counsel

Officer
51,361 -5.8%
105.00
US$5,392,905 		51,361 -5.8% 105.00 US$5,392,905
2022-02-11 2022-02-10 B Purchase
3.1
LUDWIG EDWARD J
Non-Executive Director
1,000 +5.8%
105.90
US$105,904 		1,000 +5.8% 105.90 US$105,904
2022-02-04 2022-02-03 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
47,937 -25.7%
110.00
US$5,273,070 		47,937 -25.7% 110.00 US$5,273,070
2022-02-02 2022-02-01 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
21,386 -25.9%
106.50
US$2,277,566 		21,386 -25.9% 106.50 US$2,277,566
2022-02-01 2022-01-28 PlS Planned sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
6,059 -25.7%
109.00
US$660,431 		6,059 -25.7% 109.00 US$660,431
2022-01-28 2022-01-27 PlS Planned sale
Roberts Jonathan C

EVP & Chief Operating Officer

Officer
68,482 -39.0%
107.50
US$7,361,815 		68,482 -39.0% 107.50 US$7,361,815
2021-11-05 2021-11-03 PlS Planned sale
Roberts Jonathan C

EVP & Chief Operating Officer

Officer
108,870 -50.4%
95.00
US$10,342,650 		108,870 -50.4% 95.00 US$10,342,650
2021-11-03 2021-11-01 S Sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
28,159 -16.9%
90.00
US$2,534,310 		28,159 -16.9% 90.00 US$2,534,310
2021-10-28 2021-10-26 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
80,802 -36.9%
88.00
US$7,110,576 		80,802 -36.9% 88.00 US$7,110,576
2021-10-28 2021-10-26 S Sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
1,955 -0.9%
88.00
US$172,040 		1,955 -0.9% 88.00 US$172,040
2021-06-29 2021-06-28 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
2,781 -4.4%
83.67
US$232,686 		2,781 -4.4% 83.67 US$232,686
2021-06-17 2021-06-15 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
67,552 -32.1%
86.00
US$5,809,472 		67,552 -32.1% 86.00 US$5,809,472
2021-06-08 2021-06-07 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
37,594 -61.7%
86.60
US$3,255,640 		37,594 -61.7% 86.60 US$3,255,640
2021-05-12 2021-05-10 PlS Planned sale
3.3
Moriarty Thomas M

EVP & General Counsel

Officer
109,469 -100.0%
86.00
US$9,414,334 		109,469 -100.0% 86.00 US$9,414,334
2021-05-10 2021-05-07 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
9,477 -6.1%
84.00
US$796,068 		9,477 -6.1% 84.00 US$796,068
2021-05-06 2021-05-04 PlS Planned sale
2.3
Boratto Eva C

EVP & CFO

Officer
4,905 -4.1%
80.00
US$392,400 		4,905 -4.1% 80.00 US$392,400
2021-04-23 2021-04-21 PlS Planned sale
3.3
Moriarty Thomas M

EVP & General Counsel

Officer
2,420 -100.0%
77.00
US$186,340 		2,420 -100.0% 77.00 US$186,340
2021-04-23 2021-04-21 PlS Planned sale
3.3
Moriarty Thomas M

EVP & General Counsel

Officer
101,003 -97.7%
77.00
US$7,777,231 		101,003 -97.7% 77.00 US$7,777,231
2021-04-01 2021-03-31 PlS Planned sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
5,350 -42.5%
76.00
US$406,600 		5,350 -42.5% 76.00 US$406,600
2021-03-30 2021-03-29 PlS Planned sale
3.3
Moriarty Thomas M

EVP & General Counsel

Officer
62,943 -100.0%
76.15
US$4,793,109 		62,943 -100.0% 76.15 US$4,793,109

See older CVS Health Corporation insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock CVS Health Corporation history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around CVS Health Corporation

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America
Insider trades in S&P 500